The words, “the cheap stuff” was a term that came from Baxter’s own internal records and I’m assuming it could have been emails or other reports that brought about the term maybe from a marketing area. You can read the article below where I suggested a couple of years ago to have reports electronically sent from factories to the FDA to indicate certified lot reports. These would be tamper proof and give raw data on contents. I would think both side would like this and it would help pinpoint problems immediately. Of course it’s not 100% proof, but it would certainly help. Last year B. Braun recalled a number of lots too.
FDA Heparin Investigation In Conjunction with Chinese Officials Strained and A Lot of Unfinished Business And No Technology Advances to Help the Cause
Also, while we are at it, knock off those “blind” shipments that do not show the real location of origin. There’s a lot of that going on too, many years in logistics I learned that in a hurry. BD
Baxter International has lost the first lawsuit in its ongoing legal battle over the contaminated heparin scandal in 2007 and 2008.
A US court has awarded $625,000 to the estate of Steven Johansen, who died in December 2007 after taking a Baxter heparin product contaminated with over-sulphated chondroitin sulphate (OSCS)
"The active pharmaceutical ingredient in the contaminated heparin received by Mr. Johansen and other Americans was obtained from Baxter/SPL's Chinese supplier, Changzhou SPL (a joint venture with SPL)," said the Nolan Law Group, which represented Mr. Johansen's family, in a statement.
"This crude heparin was referred to in the companies' own internal records as 'the cheap stuff'," it alleges.